1. (a) In general The Secretary of Health and Human Services may award grants to institutions of higher education and nonprofit organizations for the purpose of studying and recommending improvements to the process of continuous manufacturing of drugs and biological products and similar innovative monitoring and control techniques.

2. (b) Definitions In this section—

   1. (1) the term “drug” has the meaning given such term in section 321 of this title;
   2. (2) the term “biological product” has the meaning given such term in section 262(i) of title 42; and
   3. (3) the term “institution of higher education” has the meaning given such term in section 1001(a) of title 20.

(Pub. L. 114–255, div. A, title III, § 3016, Dec. 13, 2016, 130 Stat. 1095.)

Codification

Section was enacted as part of the 21st Century Cures Act, and not as part of the Federal Food, Drug, and Cosmetic Act which comprises this chapter.